Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of EBI-005 Ophthalmic Solution Versus Placebo in Subjects With Dry Eye Syndrome

NCT01745887 is registered in ClinicalTrials.gov with Eleven Biotherapeutics as lead sponsor.

NCT NCT01745887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01745887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double Masked, Randomized, Placebo-Controlled, Dose-Ranging Study of EBI-005 Ophthalmic Solution Versus Placebo in Subjects With Dry Eye Syndrome
Lead sponsor
Eleven Biotherapeutics
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2012
Completion date
November 30, 2012
Enrollment
74 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome